[HTML][HTML] Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular
lymphoma (FL) patients on 3 rd line of treatment (LoT) or higher, for whom existing data are …
lymphoma (FL) patients on 3 rd line of treatment (LoT) or higher, for whom existing data are …
[HTML][HTML] Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
P Ghione, ML Palomba, H Ghesquieres… - …, 2023 - haematologica.org
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study.
P Ghione, ML Palomba, H Ghesquieres, S Bobillo… - …, 2022 - europepmc.org
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
P Ghione, ML Palomba, H Ghesquieres… - …, 2022 - discovery.ucl.ac.uk
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
P Ghione, ML Palomba, H Ghesquieres… - …, 2023 - pubmed.ncbi.nlm.nih.gov
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …
[PDF][PDF] Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
P Ghione, ML Palomba, H Ghesquieres… - …, 2022 - scholar.archive.org
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular
lymphoma (FL) patients on 3 rd line of treatment (LoT) or higher, for whom existing data are …
lymphoma (FL) patients on 3 rd line of treatment (LoT) or higher, for whom existing data are …
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
P Ghione, ML Palomba, H Ghesquieres, S Bobillo… - 2022 - christie.openrepository.com
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
P Ghione, ML Palomba, H Ghesquieres… - …, 2022 - research.manchester.ac.uk
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …
[HTML][HTML] Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
P Ghione, ML Palomba, H Ghesquieres… - …, 2023 - haematologica.org
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …
lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are …